Review article · 2022 · Open access
Phage Therapy in the Era of Multidrug Resistance in Bacteria: A Systematic Review
International Journal of Molecular Sciences, 23(9), 4577 · Published 21 April 2022 · DOI 10.3390/ijms23094577
In brief
“Phage Therapy in the Era of Multidrug Resistance in Bacteria: A Systematic Review” is a 2022 review article by Carlos Aranaga and 3 co-authors, published in International Journal of Molecular Sciences. OpenAlex counts 110 citations as of 15 November 2026, which puts it in the top 2% of works published in 2022 by citations. It is open access under a CC BY licence: the full text is free to read at International Journal of Molecular Sciences.
- Citations
- 110
- Most cited in
- 2025 (36)
- Field-weighted impact
- 1.88
- References
- 45
- Authors
- 4
Abstract
Bacteriophages offer an alternative for the treatment of multidrug-resistant bacterial diseases as their mechanism of action differs from that of antibiotics. However, their application in the clinical field is limited to specific cases of patients with few or no other alternative therapies. This systematic review assesses the effectiveness and safety of phage therapy against multidrug-resistant bacteria through the evaluation of studies published over the past decade. To that end, a bibliographic search was carried out in the PubMed, Science Direct, and Google Scholar databases. Of the 1500 studies found, 27 met the inclusion criteria, with a total of 165 treated patients. Treatment effectiveness, defined as the reduction in or elimination of the bacterial load, was 85%. Except for two patients who died from causes unrelated to phage therapy, no serious adverse events were reported. This shows that phage therapy could be an alternative treatment for patients with infections associated with multidrug-resistant bacteria. However, owing to the phage specificity required for the treatment of various bacterial strains, this therapy must be personalized in terms of bacteriophage type, route of administration, and dosage.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Aranaga, C., Pantoja, L. D., Martínez, E. A., & Falco, A. (2022). Phage Therapy in the Era of Multidrug Resistance in Bacteria: A Systematic Review. International Journal of Molecular Sciences, 23(9), 4577. https://doi.org/10.3390/ijms23094577
MLA 9
Aranaga, Carlos, et al. “Phage Therapy in the Era of Multidrug Resistance in Bacteria: A Systematic Review.” International Journal of Molecular Sciences, vol. 23, no. 9, 2022, p. 4577. https://doi.org/10.3390/ijms23094577.
Chicago
Aranaga, Carlos, Lady Daniela Pantoja, Edgar Andrés Martínez, and Aura Falco. 2022. “Phage Therapy in the Era of Multidrug Resistance in Bacteria: A Systematic Review.” International Journal of Molecular Sciences 23 (9): 4577. https://doi.org/10.3390/ijms23094577.
Harvard
Aranaga, C. et al. (2022) ‘Phage Therapy in the Era of Multidrug Resistance in Bacteria: A Systematic Review’, International Journal of Molecular Sciences, 23(9), p. 4577. doi:10.3390/ijms23094577.
IEEE
C. Aranaga, L. D. Pantoja, E. A. Martínez, and A. Falco, “Phage Therapy in the Era of Multidrug Resistance in Bacteria: A Systematic Review,” International Journal of Molecular Sciences, vol. 23, no. 9, p. 4577, 2022, doi: 10.3390/ijms23094577.
BibTeX
@article{aranaga2022phage,
title = {{Phage Therapy in the Era of Multidrug Resistance in Bacteria: A Systematic Review}},
author = {Aranaga, Carlos and Pantoja, Lady Daniela and Martínez, Edgar Andrés and Falco, Aura},
journal = {International Journal of Molecular Sciences},
year = {2022},
volume = {23},
number = {9},
pages = {4577},
doi = {10.3390/ijms23094577},
url = {https://doi.org/10.3390/ijms23094577}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2022 | 6 | |
| 2023 | 10 | |
| 2024 | 28 | |
| 2025 | 36 | |
| 2026 | 30 |
Its field-weighted citation impact is 1.88: it has been cited 1.88 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
- phage therapy
- bacteriophages
- multidrug-resistant bacteria
- antibiotic resistance
- treatment effectiveness
- safety
- bacterial reduction
- personalized phage therapy
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Aranaga, C., Pantoja, L. D., Martínez, E. A., & Falco, A. (2022). Phage Therapy in the Era of Multidrug Resistance in Bacteria: A Systematic Review. International Journal of Molecular Sciences, 23(9), 4577. https://doi.org/10.3390/ijms23094577
How many times has this paper been cited?
110 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at International Journal of Molecular Sciences.
Who wrote this paper?
Carlos Aranaga, Lady Daniela Pantoja, Edgar Andrés Martínez, Aura Falco.
What is the DOI of this paper?
10.3390/ijms23094577. The permanent link is https://doi.org/10.3390/ijms23094577.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.